Rankings · Price against the business
A-graded, furthest below their high
Graded A, ranked by how far the share price sits below its 52-week high. The grade is built from the filings alone; the fall is a fact about the price, not the business.
99 companies meet this test
Figures as of October 1, 2026
| # | Company | Grade | Below 52-week high | P/E | Market value |
|---|---|---|---|---|---|
| 1 | ALHCALIGNMENT HEALTHCARE, INC. | A | -68% | 41.68 | $1.6B |
| 2 | DOCSDoximity, Inc. | A+ | -65% | 31.20 | $5.1B |
| 3 | HIMSHIMS & HERS HEALTH, INC. | A- | -54% | — | $6.6B |
| 4 | ZTSZoetis Inc. | A+ | -51% | 11.58 | $29B |
| 5 | ADMAADMA BIOLOGICS, INC. | A+ | -51% | 14.24 | $2.2B |
| 6 | ALNYALNYLAM PHARMACEUTICALS, INC. | A+ | -48% | 128.95 | $34B |
| 7 | ENOVEnovis Corp | A- | -44% | — | $1.1B |
| 8 | IRTCiRhythm Holdings, Inc. | A- | -40% | — | $3.8B |
| 9 | ACADACADIA PHARMACEUTICALS INC. | A+ | -34% | 9.07 | $3.5B |
| 10 | OMCLOMNICELL, INC | A | -33% | 40.79 | $1.6B |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.